Business Share on Facebook Share on Twitter Share on Pinterest Share on LinkedIn Hims & Hers CEO Andrew Dudum spoke to CNBC about the FTC's lawsuit against the company, compounded GLP-1 drugs and AI. Read the original report. Share on Facebook Share on Twitter Share on Pinterest Share on LinkedIn Articles You May Like United Airlines gets aggressive in battle for top Delta, American flyers Bond losses may offer investors a tax break. Here’s how tax-loss harvesting works Why airfares could rise even more, but airline profits won’t Boomers’ dividend stocks take beating from bond yields, with retirement income on the line Micron beats on earnings and issues strong guidance as data center revenue jumps 11-fold